Diabetes Franchise May Help Merck Offset Loss Of Singulair
This article was originally published in The Pink Sheet Daily
Executive Summary
The Januvia/Janumet franchise posted sales growth of 40% both in the fourth quarter and over the full year for Merck, while Isentress and Gardasil also posted strong growth rates.